A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 789,772 shares of BSX stock, worth $72.2 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
789,772
Previous 802,848 1.63%
Holding current value
$72.2 Million
Previous $61.8 Million 7.04%
% of portfolio
0.21%
Previous 0.2%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $954,024 - $1.1 Million
-13,076 Reduced 1.63%
789,772 $66.2 Million
Q2 2024

Jul 22, 2024

SELL
$67.33 - $77.71 $575,200 - $663,876
-8,543 Reduced 1.05%
802,848 $61.8 Million
Q1 2024

May 03, 2024

SELL
$57.6 - $68.62 $378,604 - $451,039
-6,573 Reduced 0.8%
811,391 $55.6 Million
Q4 2023

Jan 24, 2024

SELL
$48.64 - $57.81 $252,441 - $300,033
-5,190 Reduced 0.63%
817,964 $47.3 Million
Q3 2023

Oct 23, 2023

SELL
$50.19 - $54.68 $196,945 - $214,564
-3,924 Reduced 0.47%
823,154 $43.5 Million
Q2 2023

Jul 25, 2023

SELL
$49.72 - $54.64 $261,974 - $287,898
-5,269 Reduced 0.63%
827,078 $44.7 Million
Q1 2023

May 17, 2023

BUY
$45.09 - $50.03 $36.4 Million - $40.4 Million
806,732 Added 3149.45%
832,347 $41.6 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $36 Million - $40 Million
-798,674 Reduced 96.89%
25,615 $1.28 Billion
Q4 2022

Feb 09, 2023

SELL
$39.56 - $47.22 $1.98 Million - $2.37 Million
-50,172 Reduced 5.74%
824,289 $38.1 Million
Q3 2022

Nov 04, 2022

BUY
$36.71 - $109.66 $397,752 - $1.19 Million
10,835 Added 1.25%
874,461 $33.9 Million
Q2 2022

Aug 10, 2022

BUY
$35.24 - $47.1 $228,531 - $305,443
6,485 Added 0.76%
863,626 $32.2 Million
Q1 2022

Apr 27, 2022

SELL
$40.9 - $45.1 $18,691 - $20,610
-457 Reduced 0.05%
857,141 $38 Million
Q4 2021

Jan 31, 2022

SELL
$38.07 - $44.87 $760,334 - $896,143
-19,972 Reduced 2.28%
857,598 $36.4 Million
Q3 2021

Oct 20, 2021

SELL
$41.23 - $45.88 $1.3 Million - $1.44 Million
-31,422 Reduced 3.46%
877,570 $38.1 Million
Q2 2021

Jul 20, 2021

SELL
$38.58 - $44.24 $1.75 Million - $2.01 Million
-45,471 Reduced 4.76%
908,992 $38.9 Million
Q1 2021

Apr 22, 2021

SELL
$35.27 - $39.67 $2.7 Million - $3.04 Million
-76,644 Reduced 7.43%
954,463 $36.9 Million
Q4 2020

Feb 12, 2021

SELL
$33.15 - $41.97 $992,444 - $1.26 Million
-29,938 Reduced 2.82%
1,031,107 $37.1 Million
Q3 2020

Nov 06, 2020

SELL
$34.44 - $42.23 $3.06 Million - $3.75 Million
-88,810 Reduced 7.72%
1,061,045 $40.5 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $1.06 Million - $1.37 Million
-35,106 Reduced 2.96%
1,149,855 $40.4 Million
Q1 2020

May 13, 2020

BUY
$25.83 - $45.71 $505,854 - $895,184
19,584 Added 1.68%
1,184,961 $38.7 Million
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $60,440 - $72,410
1,596 Added 0.14%
1,165,377 $52.7 Million
Q3 2019

Nov 20, 2019

BUY
$40.31 - $43.45 $97,106 - $104,671
2,409 Added 0.21%
1,163,781 $47.4 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $173,293 - $213,352
4,964 Added 0.43%
1,161,372 $49.9 Million
Q1 2019

May 13, 2019

BUY
$32.91 - $40.75 $571,185 - $707,257
17,356 Added 1.52%
1,156,408 $43 Million
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $107,406 - $132,150
3,385 Added 0.3%
1,139,052 $40.3 Million
Q3 2018

Oct 23, 2018

SELL
$32.83 - $38.63 $836,180 - $983,906
-25,470 Reduced 2.19%
1,135,667 $43.7 Million
Q2 2018

Aug 02, 2018

SELL
$26.84 - $34.32 $42,138 - $53,882
-1,570 Reduced 0.14%
1,161,137 $38 Million
Q1 2018

Apr 10, 2018

SELL
$25.2 - $28.54 $698,871 - $791,499
-27,733 Reduced 2.33%
1,162,707 $31.8 Million
Q4 2017

Jan 22, 2018

SELL
$24.79 - $29.8 $177,174 - $212,980
-7,147 Reduced 0.6%
1,190,440 $29.5 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $31.4 Million - $34.9 Million
1,197,587
1,197,587 $34.9 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.